搜索结果: 1-7 共查到“临床医学 Cell Transplantation”相关记录7条 . 查询时间(0.048 秒)
西安交通大学医学院血液系统疾病课件 Hematopoietic stem cell transplantation (HSCT)
西安交通大学医学院 血液系统疾病 课件 Hematopoietic stem cell transplantation (HSCT)
2014/8/4
西安交通大学医学院血液系统疾病课件 Hematopoietic stem cell transplantation (HSCT)。
Twenty Years of Experience on Stem Cell Transplantation in Iran
Hematopoietic Stem Cell Transplantation Leukemia Beta-Thalassemia
2015/9/29
Background: Hematopoietic stem cell transplantation (HSCT) is a new window to therapy of many diseases. From March 1991 through April 2011, a total of 3237 HSCT were performed in the Hematology-Oncolo...
Hematopoietic Stem Cell Transplantation in Southern Iran: History,Current Status and Future Direction
Stem cell Transplantation Hematopoietic Thalassemia major Hematologic malignancy Iran
2015/9/18
Transplantation of hematopoietic stem cells (HSCT) has become the standard treatment for many patients with congenital or acquired disorders of the hematopoietic system or with chemo-radio or immuno-s...
Secondary Malignancies After Hemopoietic Stem Cell Transplantation
Hemopoietic stem cell transplantation post-transplant malignancies
2009/6/24
Hemopoietic stem cell transplantation is being carried out for rapidly increasing numbers of patients. Survival probabilities have increased progressively, and most patients return to productive lives...
The EBMT Activity Survey on Hematopoietic Stem Cell Transplantation: A novel Instrument for Quality Control
Hematopoietic stem cell transplantation transplant activity economic factors public health
2009/6/24
The hematopoietic stem cell transplant activity survey of the European Group for Blood and Marrow Transplantation (EBMT) represents a novel modern tool in health care management. Introduced in 1990, ...
Autologous stem cell transplantation with moderate dose of Idarubicin and Busulphan as conditioning regimen in acute myelogenous leukemia
Acute myeloid leukemia Stem cell transplantation Idarubicin Busulphan
2015/9/11
Background: Over 50% of patients with AML still relapse after autologous stem cell transplantation. We investigated the efficacy and feasibility of a new conditioning regimen consisting of a moderate ...
Non-Myeloablative Stem Cell Transplantation in Hematologic Malig¬nancies: An Experience from the Hematology-Oncology and BMT Re¬search Center
Hematopoietic stem cell transplantation Allogeneic Non-myeloablative Graft vs Host Dis¬ ease
2010/5/4
Background: Myeloablative-allogeneic stem cell transplantation is a common way of treating various malignant and nonma-lignant diseases; but, it is associated with hazardous immediate and late complic...